| Literature DB >> 34669978 |
Neha Kinariwalla1, Alexandra J Coromilas2, Maria C Garzon3,4, Laura E Levin3, Cynthia Magro5, Christine T Lauren3,4.
Abstract
Acquired epidermodysplasia verruciformis (AEV) describes epidermodysplasia verruciformis developing in an immunocompromised host. There is limited information in the literature regarding AEV in the pediatric population; of the patients reported, most patients described had HIV, with only two reported cases of children who developed AEV post-transplantation. This case series describes three pediatric patients who developed AEV on immunosuppressant therapy following cardiac transplantation. We review risk factors, treatment options, and prognosis of AEV in the pediatric population.Entities:
Keywords: childhood EV; immunocompromised; post-transplant AEV
Mesh:
Year: 2021 PMID: 34669978 DOI: 10.1111/pde.14701
Source DB: PubMed Journal: Pediatr Dermatol ISSN: 0736-8046 Impact factor: 1.588